二甲双胍逆转子宫内膜异位症小鼠模型中的不孕:揭示疾病通路及对未来临床方法的启示
研究用B6CBAF1小鼠建立子宫内膜异位症模型,分为内异症组(n=24)、假手术组(n=12)、内异症+二甲双胍0.5mg/ml口服3个月组(n=21)和假手术+二甲双胍组(n=16)。结果显示内异症组生育率低于假手术组(P=0.0034),二甲双胍增加每只妊娠小鼠的胎儿数(P=0.0295)并恢复生育力至对照水平,同时减缓植入物生长和血管化。结论提示二甲双胍可减轻小鼠内异症病灶的氧化应激和纤维化,显示其改善内异症不孕的潜在药理干预价值。
要点
- 内异症组生育率低于假手术组(P=0.0034),二甲双胍使每只妊娠小鼠胎儿数增加(P=0.0295)并恢复生育力至对照水平。
- 二甲双胍减缓内异症小鼠植入物生长和血管化,并使PCNA表达和纤维化水平恢复至未治疗假手术组水平。
- 在未交配小鼠中,二甲双胍降低异位内膜CYP17a1表达,上调在位内膜F4/80(P<0.0170)及异位内膜galectin-3、NFkB、HO-1和GPX-1(P<0.0293)。
核心结论
- 结果表明二甲双胍可减轻小鼠内异症模型的氧化应激和病灶纤维化,凸显其作为改善内异症不孕的潜在药理干预手段。
研究设计与样本
- 将B6CBAF1小鼠子宫碎片移植至同品系受体诱导内异症,分为内异症组(End,n=24)、假手术组(Sham,n=12)、内异症+二甲双胍0.5mg/ml口服3个月组(EndMet,n=21)和假手术+二甲双胍组(ShamMet,n=16)。
- 用超声监测植入物生长,对在位内膜(EuEnd)和异位内膜(EcEnd)的Masson三色染色切片进行计算机辅助纤维化定量。
- 通过免疫荧光和蛋白质印迹分析PCNA、CYP17a1、F4/80和galectin-3,仅通过蛋白质印迹分析NFkB、GPX-1和HO-1,统计显著性设为P<0.05。
主要发现
- 内异症模型建立成功,End组生育率低于假手术组(P=0.0034),而二甲双胍治疗增加每只妊娠小鼠的胎儿数(P=0.0295),使生育力恢复至对照水平,并减缓植入物生长和血管化。
- 二甲双胍使PCNA表达和纤维化水平恢复至未治疗EuSham小鼠水平,妊娠小鼠中PCNA表达降低(P<0.0178)。
- 在未交配小鼠中,二甲双胍降低EcEnd较未治疗EuEnd的CYP17a1表达,反之上调EuEnd组织中F4/80(P<0.0170),并上调EcEnd组织中galectin-3、NFkB及抗氧化酶HO-1和GPX-1(P<0.0293)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does metformin reverse endometriosis-associated infertility? DESIGN: Endometriosis was induced by transplanting uterus fragments from B6CBAF1 mice into recipients of the same strain. The mice were divided into groups: endometriosis (End, n = 24), sham-operated (Sham, n = 12), endometriosis with metformin (0.5mg/ml) orally administered for 3 months (EndMet, n = 21) and sham-operated metformin-treated (ShamMet, n = 16). Implant growth was monitored using ultrasonography. Fibrosis was computer-assisted quantified in Masson's trichrome-stained sections of eutopic (EuEnd) and ectopic (EcEnd) endometrium. PCNA, CYP17a1, F4/80 and galectin-3 were analysed by immunofluorescence and western blotting, and NFkB, GPX-1 and HO-1 only by western blotting. Statistical significance was set at P <0.05. RESULTS: The endometriosis model was successfully established. The End groups showed lower fertility rates than sham-operated mice (P = 0.0034), whereas metformin treatment increased the number of fetuses per pregnant mouse (P = 0.0295), restoring fertility to control levels; it also slowed implant growth and vascularization. Metformin also restored PCNA expression and fibrosis levels to those of non-treated EuSham mice. PCNA expression decreased in pregnant mice (P <0.0178). Metformin diminished CYP17a1 expression in EcEnd versus EuEnd non-treated tissues and conversely up-regulated F4/80 in EuEnd tissue (P <0.0170), and galectin-3, NFkB and the antioxidant enzymes HO-1 and GPX-1 in EcEnd tissue (P <0.0293), in non-mated mice. CONCLUSIONS: These results indicate that application of metformin can alleviate oxidative stress and mitigate fibrosis in endometriosis lesions in a murine model of endometriosis, which highlights metformin's potential as a pharmacological intervention for improving infertility in endometriosis.
引用
- Neto AC, Botelho M, Rodrigues AR, et al. Metformin reverses infertility in a mouse model of endometriosis: unveiling disease pathways and implications for future clinical approaches. Reprod Biomed Online. 2024. PMID: 39847839. doi:10.1016/j.rbmo.2024.104474
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。